Evidence map›Paper›PMID 42093915›Full record

ArticleBlood vessels, thrombosis & hemostasis2026

Factors influencing somatic genetic testing for vascular anomalies at 2 academic centers.

Katherine A King, Whitney Eng, Zoe Nelson, Anelia Charles, Meagan Corliss, Shelbie Fishman, Jeremiah Truel, Stephanie Milam, Christine Bereitschaft, Bryan A Sisk

Abstract read
In one paragraph

Article in Blood vessels, thrombosis & hemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Katherine A KingDivision of Genetic and Genomic Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.
Whitney EngDivision of Hematology/Oncology, Department of Pediatrics, Seattle Children's Hospital, Seattle, WA.
Zoe NelsonDivision of Genetic Medicine, Seattle Children's Hospital, Seattle, WA.
Anelia CharlesDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.
Meagan CorlissDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.
Shelbie FishmanDivision of Medical Education, Medical School, Washington University School of Medicine, St. Louis, MO.
Jeremiah TruelTransitional Year Program, Scripps Mercy Hospital, San Diego, CA.
Stephanie MilamDivision of Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.
Christine BereitschaftDivision of Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.
Bryan A SiskDivision of Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascular anomalies (VAs) are rare disorders with abnormal development of blood and lymphatic vasculature and surrounding tissues. Understanding the genetic etiology of VAs guides treatment with targeted inhibitors. This study compares patterns and outcomes of genetic testing in VA populations at 2 centers. Of 421 patients (mean age, 10 years; 55.6% female), 61.7% underwent prior authorization (PA) for genetic testing, 84% had their testing approved, 93% completed the testing. About 70% of the completed tests had pathogenic or likely pathogenic results. A positive result was not associated with sample type (skin biopsy vs surgical pathology; fresh vs archived). Greater odds of initiating PA were associated with presence of skin findings and male sex, whereas lower odds were associated with higher Area Deprivation Index at 1 center. This study highlights that genetic testing effectively finds causative variants, but not all patients can complete it and advocates for increased access to genetic testing.

Identifiers

PMID42093915
PMCPMC13140022

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.